Prevalence and Clinical Characteristics of Calciphylaxis in Chinese Hemodialysis Patients

Yuqiu Liu1, Canlin Yang1, Xin Yang1

  • 1Institute of Nephrology, Zhong Da Hospital, School of Medicine, Southeast University, Nanjing, China.

Frontiers in Medicine
|June 27, 2022
PubMed

Insights

The first China-based survey found calciphylaxis prevalence at 1.24% in hemodialysis patients. Early screening using multiple diagnostic methods is crucial for this severe vascular disease.

Area of Science:

  • Vascular Medicine
  • Epidemiology
  • Nephrology

Background:

  • Calciphylaxis is a severe, life-threatening vascular disease predominantly affecting patients undergoing dialysis.
  • This study represents the first epidemiological survey of calciphylaxis in China.

Purpose of the Study:

  • To determine the prevalence of calciphylaxis among hemodialysis patients in China.
  • To identify risk factors associated with calciphylaxis in this population.

Main Methods:

  • A cross-sectional survey was conducted in 24 dialysis centers in Jiangsu Province.
  • 3,867 adult hemodialysis patients (dialysis duration > 6 months) were included.
  • Diagnosis was based on characteristic skin lesions and histopathological features; skin biopsy and bone scintigraphy were utilized.

Main Results:

  • The prevalence of calciphylaxis was found to be 1.24% (48 out of 3,867 patients).
  • High prevalence of hyperparathyroidism (72.92%) was observed in calciphylaxis patients.
  • Risk factors identified include increased BMI, prolonged dialysis, warfarin therapy, hyperparathyroidism, diabetes, tumors, low serum albumin, and high serum alkaline phosphatase.

Conclusions:

  • The study establishes a baseline prevalence of 1.24% for calciphylaxis in Chinese hemodialysis patients.
  • The actual prevalence may be underestimated, highlighting the need for improved clinical awareness.
  • Multifaceted diagnostic approaches are recommended for early calciphylaxis screening.
Abstract

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
81
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
124
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
65
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
77
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations01:26

Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations

Renal calculi, commonly termed kidney stones, are crystalline solid masses that form in the kidneys but can occur at any point within the urinary system, encompassing the kidneys, ureters, bladder, and urethra.The pathophysiology of renal stones involves several key factors: supersaturation of the urine with stone-forming constituents, changes in urine pH, a decrease in urine volume, and the presence of substances that promote or inhibit stone formation.Supersaturation of Urine: This is the...
39
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
273